New radiation technique could boost immunotherapy in advanced lung cancer
NCT ID NCT06660407
First seen Mar 17, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
This study tests a special type of radiation called grid therapy, which delivers high doses to small parts of a tumor, combined with standard immunotherapy for people with stage IV non-small cell lung cancer that has stopped responding to treatment. About 20 adults will receive the combination to see if it is safe and helps shrink tumors. The goal is to improve outcomes without causing severe side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
grid radiation therapy
What this could lead to
If successful, this could offer a new treatment option for advanced lung cancer patients whose disease has worsened despite immunotherapy.
What could go wrong
This is a small early-phase trial with only 20 participants, so results may not apply broadly. There is a risk of side effects from the radiation and immunotherapy combination.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.